Alimera Sciences Reports First Quarter 2023 Results

Consolidated Net Revenue of $13.5 Million Up 14% vs. First Quarter of 2022Global End User Demand Up 14% vs. First Quarter of 2022 Financial Results and Corporate Update Conference Call Cancelled ... | May 15, 2023

Related Keywords

Switzerland ,Velan ,Switzerland General ,Scott Gordon ,Jules Abraham ,Michael Kaseta ,Adam Morgan ,Rick Eiswirth ,Capital Partners ,Alimera Sciences ,Exchange Commission ,Alimera Sciences Inc ,Nasdaq ,Globenewswire Inc ,Consolidated Net Revenue ,Corporate Update Conference Call ,Chief Executive ,Preferred Stock ,First Quarter Highlights ,Seriesb Preferred Stock ,Marketing Authorization Application ,Product Revenue ,Net Product Revenue ,Private Securities Litigation Reform Act ,Financial Condition ,Annual Report ,Quarterly Report ,Convertible Preferred ,Nc Stock Exchange ,News ,Information ,Press Release ,Onsolidated ,Pet ,Revenue ,F ,Billion ,P ,First ,Quarter ,022global ,End ,User ,Demand ,022 ,Financial ,Results ,Corporate ,Update ,Conference ,Wall ,Ancelled Alim Us0162592028 ,